FDA.reportPublic FDA data

benzocaine 0.02 MG/MG / salicylic acid 0.55 MG/MG Topical Ointment [Salinocaine]

RxCUI
1603382
RxNorm name
benzocaine 0.02 MG/MG / salicylic acid 0.55 MG/MG Topical Ointment [Salinocaine]
Display name
SALINOCAINE (Topical)
Full name
benzocaine 0.02 MG/MG / salicylic acid 0.55 MG/MG Topical Ointment [Salinocaine]
Term type
SBD
Status
Active
Strength
2-55%
Dose form
Ointment
Route
Topical
Updated
2026-10-15 15:45:14

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
042015
Active start
042015
Multiple ingredient
YES
Branded
YES

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
benzocaine0.02 MG / 1 MGbenzocainebenzocaine
salicylic acid0.55 MG / 1 MGsalicylic acidsalicylic acid

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Topical Ointment316985

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
benzocaine1399
salicylic acid9525

Source Vocabulary Codes#

Code type, Values, Count table
Code typeValuesCountCategory
PRESCRIBABLEY1ATTRIBUTES
RXNAV_STRSalinocaine (benzocaine 2 % / salicylic acid 55 % ) Topical Ointment1NAMES
RxNorm Namebenzocaine 0.02 MG/MG / salicylic acid 0.55 MG/MG Topical Ointment [Salinocaine]1NAMES
RxNorm SynonymSalinocaine (benzocaine 2 % / salicylic acid 55 % ) Topical Ointment1NAMES
TTYSBD1ATTRIBUTES
SPL_SET_ID49d9f83d-3055-f80e-e58a-b6fca192ac8d1CODES
RxCUI16033821CODES

FDA NDC Products And Packages#

Package NDC, Product NDC, Name table
Package NDCProduct NDCNameLabelerApplication
10733-415-4010733-415Salinocaine salicylic acid and benzocaineMedical Products Laboratories, Inc.

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 1 matching rows.

NDC11, Source, Active table
NDC11SourceActive
10733041540rxnav_ndcsyes

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
SalinocaineSALICYLIC ACID AND BENZOCAINEMedical Products Laboratories, Inc.49d9f83d-3055-f80e-e58a-b6fca192ac8d2024-08-07Exact identifier
ndc (package): 10733-415-40
ndc (product): 10733-415
ndc11 (package): 10733041540
rxcui: 1603382

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
49d9f83d-3055-f80e-e58a-b6fca192ac8dSalinocaine (salicylic acid 550 MG / benzocaine 20 MG) per GM Topical Ointment [PSN] · benzocaine 0.02 MG/MG / salicylic acid 0.55 MG/MG Topical Ointment [Salinocaine] [SBD] · Salinocaine (benzocaine 2 % / salicylic acid 55 % ) Topical Ointment [SY]39SALINOCAINE OINTMENT20240807

Recently Linked DailyMed Labels#

Set ID, Title, Manufacturer table
Set IDTitleManufacturerEffective
49d9f83d-3055-f80e-e58a-b6fca192ac8dSALINOCAINE OINTMENTMedical Products Laboratories, Inc.20240807

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCD04ABAnesthetics for topical useATC1-4benzocaine
ATCR02ADAnesthetics, localATC1-4benzocaine
ATCS01BCAntiinflammatory agents, non-steroidsATC1-4salicylic acid
ATCN01BAEsters of aminobenzoic acidATC1-4benzocaine
ATCC05ADLocal anestheticsATC1-4benzocaine
ATCD01AEOther antifungals for topical useATC1-4salicylic acid
FDASPLN0000185508Standardized Chemical AllergenEPChas_epcbenzocaine
FDASPLN0000184306Cell-mediated ImmunityPEhas_pebenzocaine
FDASPLN0000175629Increased Histamine ReleasePEhas_pebenzocaine
MEDRTD001566BenzocaineCHEMhas_ingredientbenzocaine
MEDRTD020156Salicylic AcidCHEMhas_ingredientsalicylic acid
MEDRTD000152Acne VulgarisDISEASEmay_treatsalicylic acid
MEDRTD001424Bacterial InfectionsDISEASEci_withbenzocaine
MEDRTD002056BurnsDISEASEmay_treatbenzocaine
MEDRTD012628Dermatitis, SeborrheicDISEASEmay_treatsalicylic acid
MEDRTD004342Drug HypersensitivityDISEASEci_withsalicylic acid
MEDRTD004342Drug HypersensitivityDISEASEci_withbenzocaine
MEDRTD004433EaracheDISEASEmay_treatbenzocaine
MEDRTD005401Fissure in AnoDISEASEmay_treatbenzocaine
MEDRTD006484HemorrhoidsDISEASEmay_treatbenzocaine
MEDRTD006561Herpes SimplexDISEASEmay_treatbenzocaine
MEDRTD017492Keratosis, SeborrheicDISEASEmay_treatsalicylic acid
MEDRTD019226Oral UlcerDISEASEmay_treatbenzocaine
MEDRTD010032Otitis ExternaDISEASEmay_treatbenzocaine
MEDRTD010033Otitis MediaDISEASEmay_treatbenzocaine
MEDRTD010146PainDISEASEmay_preventbenzocaine
MEDRTD011537PruritusDISEASEmay_treatbenzocaine
MEDRTD011565PsoriasisDISEASEmay_treatsalicylic acid
MEDRTD012536Scalp DermatosesDISEASEmay_treatsalicylic acid
MEDRTD014098ToothacheDISEASEmay_treatbenzocaine
MEDRTD014860WartsDISEASEmay_treatsalicylic acid
MEDRTN0000000180Sodium Channel InteractionsMOAhas_moabenzocaine
MEDRTN0000009915Unknown Cellular or Molecular InteractionMOAhas_moasalicylic acid
MEDRTN0000008889Decreased Sensory-Somatic Nervous System Organized Electrical ActivityPEhas_pebenzocaine
MEDRTN0000009974Increased Skin KeratinizationPEhas_pesalicylic acid

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESAVAILABLE_STRENGTH0.02 MG/MG / 0.55 MG/MG
ATTRIBUTESGENERAL_CARDINALITYMULTI
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESRXNAV_HUMAN_DRUGUS
NAMESPrescribable SynonymSalinocaine (salicylic acid 550 MG / benzocaine 20 MG) per GM Topical Ointment
SOURCESSourceMetathesaurus FDA Structured Product Labels